-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Esophagectomy is a major operation involving the chest and abdomen, so pain control must support recovery without creating avoidable respiratory, gastrointestinal or neurological complications. A well-designed perioperative plan begins before anaesthesia and continues through hospital discharge, combining regional techniques, non-opioid medicines, carefully titrated opioids and regular reassessment.
For Australian patients, this approach fits closely with enhanced recovery principles used in major centres such as Sydney, Melbourne, Brisbane and Perth. It also needs to account for local referral pathways, travel from rural areas, hospital formularies and the practical realities of follow-up after a long admission. Education shared through specialist forums such as the International Society for Diseases of the Esophagus remains valuable for teams refining these pathways.
Pain after an open or minimally invasive esophagectomy can limit deep breathing, coughing and mobilisation. Those effects increase the risk of atelectasis, chest infection, delayed rehabilitation and venous thromboembolism. Poorly controlled pain may also interfere with sleep, nutrition and participation in physiotherapy.
Excessive analgesia presents a different set of problems. Opioid-related sedation can impair respiratory effort, while nausea, ileus and constipation can delay enteral feeding. The best plan therefore aims for functional comfort: the patient should be able to breathe deeply, get out of bed and complete essential exercises while remaining alert enough to report changing symptoms.
Preoperative assessment should identify chronic pain, previous opioid exposure, sleep apnoea, renal or hepatic impairment, frailty and medicines that may interact with analgesics. Patients benefit from clear information about expected pain, the purpose of epidural or regional analgesia, safe opioid use and the importance of mobilisation. This conversation can reduce fear while setting realistic expectations that some discomfort is normal during recovery.
A multidisciplinary discussion between the surgeon, anaesthetist, acute pain service, nursing staff, physiotherapists and dietitians is particularly important. In Australia, patients transferred to tertiary hospitals from regional New South Wales, Queensland or Western Australia may need extra discharge planning because follow-up can involve long drives or flights. A written medication schedule and communication with the local general practitioner help maintain continuity.
Multimodal analgesia combines medicines and techniques that act through different pathways. Regular paracetamol is commonly used when clinically appropriate, while anti-inflammatory medicines may be considered after checking renal function, bleeding risk, anastomotic concerns and the surgeon’s preference. Low-dose ketamine or other specialist-directed medicines can have a role in selected opioid-tolerant patients.
Thoracic epidural analgesia has traditionally been used for open esophagectomy, although its benefits must be balanced against hypotension, urinary retention, motor block and technical limitations. Paravertebral blocks, erector spinae plane blocks and wound or intercostal techniques may be alternatives in suitable patients. The choice should reflect the surgical approach, local expertise and the need for early mobilisation rather than relying on a single standard method.
Pain scores are useful, but they should be paired with functional measures such as coughing, incentive spirometry, walking and sleep. Nurses should assess sedation, respiratory rate, oxygenation, nausea, bowel function and delirium risk. A sudden escalation in pain, especially with tachycardia, fever, breathlessness or abdominal findings, requires clinical review rather than automatic increases in analgesics.
Patient-controlled analgesia can provide autonomy during the early postoperative period, but settings need regular review as pain changes and oral intake improves. The transition to oral medicines should occur before discharge, with the smallest reasonable opioid supply and explicit instructions about driving, alcohol, storage and disposal. Australian hospitals may use different electronic prescribing and pharmacy systems, so the discharge list should be reconciled carefully with the patient’s pre-admission medicines.
Discharge planning should cover wound discomfort, swallowing or feeding changes, constipation prevention, sleep, activity and warning signs. Patients and carers should know whom to contact if pain suddenly worsens or is accompanied by fever, vomiting, breathlessness or inability to maintain hydration. Those travelling back to communities outside Melbourne, Sydney or other capital cities may need an earlier review plan and reliable access to prescribed medicines.
Professional education can help teams compare evolving evidence and local practice. Although the 2021 ISDE congress was a virtual event, its educational context reflects the value of shared specialist knowledge; archived registration information also illustrates how clinicians accessed congress resources and scientific sessions. Local protocols should still be adapted to each hospital’s pharmacy availability, acute pain expertise and postoperative surgical pathway.
A reliable pathway is easier to deliver when responsibilities are documented in the electronic medical record and reinforced during daily ward rounds. It should state who reviews epidurals or nerve blocks, when rescue analgesia is escalated, how constipation is prevented and which clinical findings trigger surgical assessment. Audit measures might include time to mobilisation, opioid consumption, respiratory complications, unplanned intensive care admission and patient-reported pain interference.
The immediate next step is to bring the surgeon, anaesthetist, acute pain clinician, pharmacist and ward physiotherapist together to approve a written esophagectomy analgesia pathway, including discharge instructions and a follow-up contact for patients returning to regional Australia.